13 Sep Platypus Technologies awarded $600K federal grant
Madison, Wis. – Platypus Technologies, a Madison-based life sciences nanotechnology company, has been awarded a Phase I Small Business Innovation Research grant for $600,000 from the National Institute of Allergy and Infectious Diseases.
The funds will be used to develop hepatitis screening assays that can simultaneously detect multiple proteins from a single sample. The assays will use the company’s liquid crystal-based technology for rapid detection of molecular interactions.
To date, Platypus Technologies has received over $15.5 million in federal funding to develop nanotechnology products for the physical and life sciences. The company, which is developing several “nano-based” technologies for use by researchers, employs 21 people and is located in the Fitchburg Technology Campus.
• Platypus secures $2.3 million contract with Maryland biological center
• Platypus Technologies launches new research tool
• New Platypus Technologies CEO ready for key product launch
• Platypus Technologies appoints Jeff Williams as CEO
• Platypus Technologies secures $450K SBIR grant